利妥昔单抗治疗婴儿难治性自身免疫性溶血性贫血伴假性血小板减少一例报告附文献复习
被引量:2
摘要
自身免疫性溶血性贫血(AIHA)系体内B淋巴细胞免疫调节紊乱,产生自身抗体和(或)补体,并结合于红细胞膜上,致红细胞破坏加速而引起的一组溶血性贫血。婴儿难治性AIHA症状重,病程迁延,病死率高,治疗目标是迅速控制溶血。利妥昔单抗治疗成人原发免疫性血小板减少症(ITP)、AIHA及Evans综合征安全有效。
出处
《中华血液学杂志》
CAS
CSCD
北大核心
2012年第11期957-959,共3页
Chinese Journal of Hematology
参考文献19
-
1Motta M, Cavazza A, Migliori C,et al. Autoimmune haemolytic anaemia in a newborn infant. Arch Dis Child Fetal Neonatal Ed, 2003,88 : 341-342.
-
2Ng PC, Lee KK, Lo AF,et al. Anti-B cell targeted immunotherapy for treatment of refractory autoimmune haemolytic anaemia in a young infant. Arch Dis Child, 2003,88:337-339.
-
3Pefialver FJ, Alvarez-Larrdn A, Diez-Martin JL,et al. Rituximab is an effective arid safe therapeutic alternative in adults with refrac- tory and severe autoimmune hemolytic anemia. Ann Hematol, 2010,89 : 1073-1080.
-
4Vaglio S, Arista MC, Perrone MP, et al. Autoimmune hemolytic anemia in childhood: serologic features in 100 cases. Transfusion, 2007,47:50-54.
-
5Svahn J, Fioredda F, Calvillo M, et al. Rituximab-based immuno- suppression for autoimmune haemolytic anaemia in infants. Br J Haematol, 2009,145:96-100.
-
6Stasi R. Rituximab in autoimmune hematologic diseases: not just a matter of B cells. Semin Hematol, 2010,47:170-179.
-
7Taylor RP, Lindorfer MA. Drug insight the mechanism of action of rituximab in autoimnmne disease the immune complex decoy hy-pothesis. Nat Clin Pract Rheumatol, 2007,3:86-95.
-
8Bader-Meunier B, Aladjidi N, Bellmann F,et al. Rituximab thera- py for childhood Evans syndrome. Haematologica, 2007,92:1691- 1694.
-
9Zecca M, Nobili B, Ramenghi U, et al. Rituximab for "the treat- ment of refractory autoimmune hemolytic anemia in children. Blood, 2003,101:3857-3861.
-
10Dierickx D, Verhoef G, Van Hoof A, et al. Rituximab in auto- immune haemolytie anaemia and immune thrombocytopenic purpu- ra: a Belgian retrospective multicentrie study. J Intern Med, 2009, 266:484-491.
同被引文献16
-
1赵湜,王红祥,李菁媛,毛红,邹萍.调节性T细胞在慢性特发性血小板减少性紫癜中的作用[J].中华血液学杂志,2006,27(3):203-205. 被引量:17
-
2Sakaguchi S, Yamaguchi T, Nomura T, et al. Regulatory T ceils and immune tolerance [ J ]. Ce11,2008,133 (5) :775-787.
-
3Liu MF,Wang CR,Fung LL,et al. Decreased CD4+ CD+T cells in peripheral blood of patients with systemic lupus erythematosus [J]. Scand J Immunol,2004,59(2) :198-202.
-
4Crispin JC, Martines A, Alcocer-Varela J. Quantification of regula- tory T-cells in patients with systemic lupus erythematosus [ J ]. J Autoimmun ,2003,21 (3) :273-276.
-
5Chen J, Ellison FM, Eckhaus MA, et al. Minor antigen H60-medi- ated aplastic anemia is ameliorated by immunosuppression and the infusion of regulatory T-cells [ J ]. J Immunol, 2007,178 ( 7 ) : 4159-4168.
-
6Yu J ,Heck S,Patel : ,el al. Defective circulating CD25 regulate-ry T cells in patients with chronic immune thrombocytopenic pur- pura[J]. Blood,2008,112(4) :1325-1328.
-
7Mqadmi A, Zheng XY, Yazdanbakhah K. CD4+ CD5+ regulatory T cells control induction of autoimmune hemolytic anemia [ J ]. Blood,2005,105 (9) :3746-3748.
-
8Brunkow ME, Jeffery EW, Hjerrild KA, et al. Disruption of a new forkhead/winged-helix protein, scurfin, results in the fatal lym- phoproliferative disorder of the scurfy mouse [ J ]. Nat. Genet, 2001,27( 1 ) :68-73.
-
9Hod S, Nomura T, Sakaguchi S. Control of regulatory T cell devel- opment by the transcription factor Foxp3 [ J ]. Science, 2003,299 ( 1 ) : 1057-1061.
-
10Marson A, Kretschmer K, Frampton GM, et al. Foxp3 occupancy and regulation of key target genes during T-cell stimulation [ J ]. Nature ,2007,445 (7130) :931-935.
二级引证文献5
-
1阎羽欣,陈广洁.适应性免疫细胞在自身免疫性溶血性贫血发病机制中的研究进展[J].中国免疫学杂志,2020,36(11):1392-1396. 被引量:9
-
2郑宇霞,段丽芬,李亚玲,周玲,潘晓洁,王惠萍.利妥昔单抗治疗儿童难治性免疫性脑炎的效果[J].临床药物治疗杂志,2020,18(8):18-22. 被引量:1
-
3邹丽萍.血型基因检测在自身免疫性溶血性贫血患者输血治疗中的应用研究[J].当代医学,2021,27(35):23-25. 被引量:4
-
4孟祎,吴玉斌,雷晔飞,曲强,郝志宏,于力,张瑶,周萍,张思佳,刘雪梅,张洪霞,潘艳艳,董丽群,陶于洪,张利娟,张建江,贾莉敏,刘俊梅,刘翠华,厉洪江,李广波,中国医师协会儿科医师分会血液净化专业委员会.血浆置换治疗儿童自身免疫性溶血性贫血疗效分析[J].中国小儿急救医学,2022,29(9):691-695. 被引量:1
-
5郝会民,李杨世玉,黄爱,刘晓景,曹冰燕,卫海燕.儿童自身免疫性多内分泌腺病综合征Ⅰ型2例并文献复习[J].安徽医药,2024,28(9):1871-1875.
-
1李娟.假性血小板减少163例临床分析[J].中国医学工程,2012,20(11):23-24. 被引量:4
-
2张梅,邵文斌.达那唑治疗难治性自身免疫性溶血性贫血3例[J].陕西医学杂志,1991,20(4):203-204. 被引量:1
-
3曹钦秋.品管圈在降低末梢血假性血小板减少发生率的应用[J].大家健康(学术版),2015(3):25-26. 被引量:1
-
4刘鸿,邢莉民,王化泉,吴玉红,瞿文,梁勇,王国锦,宋嘉,王晓明,关晶,李丽娟,付蓉,邵宗鸿.利妥昔单抗联合环磷酰胺治疗七例难治性自身免疫性溶血性贫血的长期疗效和安全性[J].中华内科杂志,2012,51(6):456-459. 被引量:6
-
5曹燕,刘菊珍,尹更生.急性心肌梗死伴假性血小板减少1例并文献复习[J].临床荟萃,2005,20(23):1357-1359.
-
6血小板疾病[J].国外科技资料目录(医药卫生),1998(11):37-37.
-
7田维娟,侯霞,张之.EDTA依赖性假性血小板减少检测方法的探讨[J].大家健康(学术版),2016(14). 被引量:1
-
8孙兆金,莫剑忠.炎症性肠病的生物治疗[J].中国临床药学杂志,2006,15(3):134-136.
-
9陶金辉,李向培.趋化因子及受体与系统性红斑狼疮[J].临床内科杂志,2005,22(2):142-144. 被引量:5
-
10张卫平.中医药治疗溃疡性结肠炎机制研究进展[J].中国中医急症,2011,20(9):1468-1471. 被引量:4